Single-cell mitochondria profiling (scmitop) for immune disorders

Overview

The Single-cell Mitochondria Profiling (scMITOp) technology offers a groundbreaking approach to analyzing mitochondrial function at the single-cell level in immune cells. This innovative tool leverages mass cytometry to measure over 40 parameters per cell, providing detailed insights into mitochondrial dynamics, electron transport, mitophagy, and other key processes. The ability to simultaneously study these parameters in diverse immune cells such as T, B, and NK lymphocytes, as well as monocytes and dendritic cells, holds significant potential for developing new therapeutic strategies for immune-driven diseases like rheumatoid arthritis, systemic lupus erythematosus, type I diabetes, multiple sclerosis, and sepsis.

Technical specifications

Key features:

• Utilizes high-dimensional mass cytometry for detailed profiling of mitochondrial functionality
• Capable of measuring proteins involved in various metabolic pathways, such as IDH, CS, OGDH, ATP5A, and others
• Identifies subpopulations of immune cells including T, B, and NK lymphocytes, monocytes, and dendritic cells
• Targets proteins linked to mitochondrial dynamics, mitophagy, and antioxidant response
• Facilitates the study of signaling and transcription factors related to immune cell function

Technology readiness level

The scMITOp tool is currently at Technology Readiness Level 3. It is in the active development phase, with initial validation planned through assays on patients with various immune-related disorders. This validation will involve testing peripheral blood mononuclear cells from patient cohorts, including those with rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and severe sepsis, to ensure efficacy and reliability in real-world applications.